BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10211138)

  • 1. Olanzapine in the long-term treatment of schizophrenia.
    Kane J
    Br J Psychiatry Suppl; 1999; (37):26-9. PubMed ID: 10211138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The routine use of atypical antipsychotic agents: maintenance treatment.
    Kinon BJ
    J Clin Psychiatry; 1998; 59 Suppl 19():18-22. PubMed ID: 9847048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked reduction of tardive dyskinesia with olanzapine.
    Littrell KH; Johnson CG; Littrell S; Peabody CD
    Arch Gen Psychiatry; 1998 Mar; 55(3):279-80. PubMed ID: 9510225
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine for the treatment of tardive dyskinesia.
    Almeida OP
    J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia associated with olanzapine monotherapy.
    Ananth J; Kenan J
    J Clin Psychiatry; 1999 Dec; 60(12):870. PubMed ID: 10665640
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dyskinesia in affective disorders.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 5():43-7; discussion 48-9. PubMed ID: 10192407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic drugs and long-term outcome in schizophrenia.
    Weiden P; Aquila R; Standard J
    J Clin Psychiatry; 1996; 57 Suppl 11():53-60. PubMed ID: 8941171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine.
    Lykouras L; Agelopoulos E; Tzavellas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):815-7. PubMed ID: 12188112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia associated with olanzapine.
    Herrán A; Vázquez-Barquero JL
    Ann Intern Med; 1999 Jul; 131(1):72. PubMed ID: 10391826
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject.
    O'Brien J; Barber R
    Br J Psychiatry; 1998 Feb; 172():186. PubMed ID: 9519075
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
    Agarwal V; Kumar P
    J Clin Psychiatry; 2001 Apr; 62(4):298-9. PubMed ID: 11379849
    [No Abstract]   [Full Text] [Related]  

  • 14. Risperidone and tardive dyskinesia: a case of blepharospasm.
    Mullen A
    Aust N Z J Psychiatry; 2000 Oct; 34(5):879-80. PubMed ID: 11037386
    [No Abstract]   [Full Text] [Related]  

  • 15. Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine.
    Ipekçi S; Birsöz S
    Eur Psychiatry; 2001 Jun; 16(4):259-60. PubMed ID: 11418277
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.
    Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D
    Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
    Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
    Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine therapy in elderly patients with schizophrenia.
    Sajatovic M; Perez D; Brescan D; Ramirez LF
    Psychopharmacol Bull; 1998; 34(4):819-23. PubMed ID: 10513458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.